Laprituximab
Product Specifications
CAS Number
1622327-38-1
Target
EGFR
Related Pathways
Angiogenesis|||JAK/STAT signaling|||Tyrosine Kinase/Adaptors
Purity
0.9962
Bioactivity
Laprituximab (J2898A) is a humanized anti-EGFR antibody used for synthesizing ADC compound Laprituximab emtansine.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1370976-01 0.02 mg (E-Coli)
Recombinant Francisella tularensis subsp. tularensis Recombination protein RecR (recR)
Ask
View Details 
MBS1370976-02 0.1 mg (E-Coli)
Recombinant Francisella tularensis subsp. tularensis Recombination protein RecR (recR)
Ask
View Details MBS1370976-03 0.02 mg (Yeast)
Recombinant Francisella tularensis subsp. tularensis Recombination protein RecR (recR)
Ask
View Details 
MBS1370976-04 0.1 mg (Yeast)
Recombinant Francisella tularensis subsp. tularensis Recombination protein RecR (recR)
Ask
View Details 
MBS1370976-05 0.02 mg (Baculovirus)
Recombinant Francisella tularensis subsp. tularensis Recombination protein RecR (recR)
Ask
View Details MBS1370976-06 0.02 mg (Mammalian-Cell)
Recombinant Francisella tularensis subsp. tularensis Recombination protein RecR (recR)
Ask
View Details